Please login to the form below

Moving away from pharma’s paternalistic approach

New handbook makes the case for greater patient engagement in the development of new medicines

12 September 2018, Cambridge, UK—The pharmaceutical industry has achieved great success in delivering innovative medicines, but life science companies must become ever more consumer-centric if they are to realise the step change in improving patient outcomes that their science promises, according to a new patient engagement handbook released today.



Patient Engagement for the Life Sciences
by Guy Yeoman and Mitchell Silva explains the ‘why’ and the ‘how’ of patient engagement, presenting the compelling argument for why life science companies need to embrace and partner with patients and outlining an operating framework for doing it effectively.


“It’s so important to shift from patient-centric rhetoric to an integrated model where life cycle decisions are informed by patient insight and patient solutions are created with patients,” Yeoman commented.

Guy Yeoman has worked for the last two decades in the pharmaceutical industry, and in the last three years he built a patient-engaging capability in a large pharma organisation. Mitchell Silva is a patient expert and Chair of the European Patients’ Academy (EUPATI) in Belgium. They are co-founders of MediPaCe, a strategic consultancy that works with the life science industry to make patient engagement a reality.



In Patient Engagement for the Life Sciences, the authors discuss the future of the pharmaceutical industry and how a number of drivers — including digital technology, patient expectations, outcomes-based payments and spiralling R&D costs — will make co-creating medicines with patients crucial to pharma companies’ ability to continue to deliver patient value.


It goes on to describe the framework necessary for embedding patient engagement into business practice, and the process for transforming into a company with patients at the centre of its culture.

Silva said, “Patients increasingly want to contribute to the development of better medicines and better services to support new treatments, but often the infrastructure to involve patients in a structural way is lacking. Patients are waiting to contribute.”  

Cuttsy+Cuttsy provided editorial support, cover design and illustrations for the publication. Director Caroline Benson said, “As a healthcare communications agency where people matter, Guy and Mitchell’s book aligned perfectly with our company values. We were delighted to help bring it to life, as working with patients to make sure products and services work for them is what we have always done, and we truly believe that it gives the best results for everyone.”

Patient Engagement for the Life Sciences
is now available as an eBook. Any profits generated from book sales will be donated to International Health Partners UK, Europe’s largest coordinator of donated medicines, to support patients around the world.


Download your copy from www.medipace.com/book

12th September 2018

Share

Tags

Company Details

Cuttsy + Cuttsy

+44 (0) 1223 967222

Contact Website

Address:
Abbey Barns
Duxford Road
Ickleton
Cambridge
CB10 1SX
United Kingdom

Latest content on this profile

Cuttsy+Cuttsy launch their latest patient e-book
On the eve of ‘World Osteoporosis Day’ (worldosteoporosisday.org), Cuttsy+Cuttsy are proud to launch their latest e-book ‘Osteoporosis…in plain English’.
Cuttsy + Cuttsy
Insights from the charity sector – from patient engagement to people-driven design
Marianne Guldbrandsen, Strategy Director at Cuttsy+Cuttsy and former Head of Innovation and Strategic Partnerships at Macmillan, discusses how people-driven research leads to truly patient-centred products and services, and what the pharmaceutical industry can learn about this from the charity sector.
Cuttsy + Cuttsy
Patient Engagement for the Life Sciences
Patient Engagement for the Life Sciences, written by Guy Yeoman and Mitchell Silva with editorial and design support from Cuttsy+Cuttsy, explains the ‘why’ and the ‘how’ of patient engagement. It presents the compelling argument for why life science companies need to embrace and partner with patients and outlining an operating framework for doing it effectively. Visit www.medipace.com/book to download your copy.
Cuttsy + Cuttsy
Moving away from pharma’s paternalistic approach
New handbook makes the case for greater patient engagement in the development of new medicines
Cuttsy + Cuttsy
Why patient education isn’t simple
The terms patient education, patient activation and patient engagement are increasingly popular as healthcare becomes more patient-centric. In this article, Clare Mariconda discusses how the concepts link together and shares practical ways to first engage patients so they can be educated and ultimately take action that positively impacts on their own health.
Cuttsy + Cuttsy
Empowered patients improve outcomes
This white paper co-authored by our own Caroline Benson and Guy Yeoman, MediPaCe, discusses why non-adherence is occurring, how patients’ can be better engaged with their conditions and treatments and provides examples and results of patient engagement in action.
Cuttsy + Cuttsy